通过WGCNA分析获得的尾炎枢纽基因的诊断价值评估和门德尔随机化研究
Lian-Shuo Li1, Yue Tong, Chao Yuan
1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Medicine
|September 10, 2024
概括
这项研究确定了五个关键基因 (HSP90AA1,RPL5,MYC,CD44,RPS3A),这些基因对尾炎具有诊断意义,提高了对其分子通路和肠道微生物群相关性的理解.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 准确的尾炎诊断对于有效的治疗至关重要.
- 了解尾炎的分子基础对于改善诊断策略至关重要.
研究的目的:
- 为了识别与尾炎相关的诊断枢纽基因.
- 探索尾炎的病理生理学和分子途径.
- 研究尾炎,肠道微生物群和免疫细胞透之间的关系.
主要方法:
- 使用了差异基因表达分析和加权基因共同表达网络分析 (WGCNA).
- 基因和基因组的京都百科全书 (KEGG) 和基因本体学 (GO) 分析进行了功能丰富.
- 纳米图和接收机操作员特征 (ROC) 曲线评估了诊断效率.
- 门德尔随机化 (MR) 检查了因果关系.
主要成果:
- 在尾炎和其他腹部疼痛群体中发现了757个共同的基因.
- 枢纽基因 (HSP90AA1,RPL5,MYC,CD44,RPS3A) 显示出对尾炎的诊断意义.
- 发现尾炎与9种特定的肠道微生物群相关.
- 通过MR的枢纽基因和尾炎之间没有建立起因果关系.
结论:
- 五个枢纽基因 (HSP90AA1,RPL5,MYC,CD44,RPS3A) 被确定为尾炎的潜在诊断生物标志物.
- 这些发现有助于更好地了解尾炎的分子机制.
- 这项研究强调了尾炎和肠道微生物群组成之间的相关性.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
18.9K
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
3.6K
相关概念视频
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
